Anticancer Research: international journal of cancer research and treatment

Journal

Publication Venue For

  • Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.  42:1381-1396. 2022
  • A rare case of progressive malignant triton tumor with rare somatic mutation in TSC2 gene.  41:3029-3036. 2021
  • Therapeutic time-restricted feeding reduces renal tumor bioluminescence in mice but fails to improve anti-CTLA-4 efficacy.  40:5445-5456. 2020
  • Noncalcemic Vitamin D hydroxyderivatives inhibit human oral squamous cell carcinoma and down-regulate hedgehog and WNT/β-catenin pathways.  40:2467-2474. 2020
  • Relevance of Vitamin D in melanoma development, progression and therapy.  40:473-489. 2020
  • SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly through the Modulation of cIAP2.  40:9-26. 2020
  • CD133 expression as a helicobacter pylori-independent biomarker of gastric cancer progression.  38:4443-4448. 2018
  • Addition of rituximab to chemotherapy reduced the rate of surgery for gastric-DLBCL without increasing early mortality.  37:813-818. 2017
  • Chest wall deformity in the radiation oncology clinic.  36:5295-5300. 2016
  • Effect of adjuvant radiotherapy on survival in patients with locoregional urothelial malignancies of the upper urinary tract.  36:4051-4055. 2016
  • Design, synthesis and biological activities of novel gemini 20s-hydroxyVitamin D3 analogs.  36:877-886. 2016
  • Induction of acute myeloid leukemia with idarubicin, cytarabine and cladribine.  35:6287-6290. 2015
  • Population-based analysis of the clinical features of primary small cell carcinoma of the ovary.  35:3091-3096. 2015
  • Decreased VDR expression in cutaneous melanomas as marker of tumor progression: New data and analyses.  34:2735-2744. 2014
  • Novel vitamin D analogs as potential therapeutics: Metabolism, toxicity profiling, and antiproliferative activity.  34:2153-2164. 2014
  • Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes.  32:3733-3742. 2012
  • 20-Hydroxyvitamin D 3 inhibits proliferation of cancer cells with high efficacy while being non-toxic.  32:739-746. 2012
  • Dual-mode interaction between quercetin and DNA-damaging drugs in cancer cells.  32:61-71. 2012
  • Suppression by L-methionine of cell cycle progression in LNCaP and MCF-7 cells but not benign cells.  30:1881-1885. 2010
  • Bevacizumab is active as a single agent against recurrent malignant gliomas.  30:609-611. 2010
  • Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells.  29:4959-4964. 2009
  • Epigenetic modifications of the estrogen receptor β gene in epithelial ovarian cancer cells.  29:139-144. 2009
  • Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma.  27:883-888. 2007
  • Capsaicin-mediated Denervation of Sensory Neurons Promotes Mammary Tumor Metastasis to Lung and Heart.  24:1003-1009. 2004
  • Green tea polyphenol targets the mitochondria in tumor cells inducing caspase 3-dependent apoptosis.  23:1533-1539. 2003
  • Induction of p57 is required for cell survival when exposed to green tea polyphenols.  22:4115-4120. 2002
  • Expression of DNA topoisomerase IIα in oligodendroglioma.  22:1301-1304. 2002
  • Expression of DNA topoisomerase IIalpha in oligodendroglioma..  22:1301-1304. 2002
  • Chemopreventive effects of green tea polyphenols correlate with reversible induction of p57 expression.  21:3743-3748. 2001
  • Effect of mammalian lignans on the growth of prostate cancer cell lines.  21:3995-3999. 2001
  • Chemopreventive effects of green tea polyphenols correlate with reversible induction of p57 expression..  21:3743-3748. 2001
  • Effect of mammalian lignans on the growth of prostate cancer cell lines..  21:3995-3999. 2001
  • Effect of high retinoid doses on RAR-β mRNA expression in female B6D2F1 mice.  21:1691-1695. 2001
  • Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs.  21:1173-1180. 2001
  • A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma.  20:3647-3655. 2000
  • A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma..  20:3647-3655. 2000
  • Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia.  20:1751-1757. 2000
  • Longitudinal analysis of mammary cancer multiplicity in chemoprevention studies.  20:2281-2287. 2000
  • Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia..  20:1751-1757. 2000
  • Cellular delivery is a major obstacle for oligodeoxynucleotide inhibition of telomerase activity.  18:4105-4108. 1998
  • Synergistic therapy of breast cancer with Y90-chimeric L6 and paclitaxel in the xenografted mouse model: Development of a clinical protocol.  18:4011-4018. 1998
  • Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: Selective review and hypothesis.  18:3709-3715. 1998
  • Inhibition of melanogenesis as an adjuvant strategy in the treatment of melanotic melanomas: selective review and hypothesis..  18:3709-3715. 1998
  • Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: a pilot study..  18:2779-2788. 1998
  • Maximum tolerated dose of 67Cu-2IT-BAT-LYM-1 for fractionated radioimmunotherapy of non-Hodgkin's lymphoma: A pilot study.  18:2779-2788. 1998
  • TPA-mediated regulation of osteopontin in human malignant glioma cells.  18:807-812. 1998
  • TPA-mediated regulation of osteopontin in human malignant glioma cells..  18:807-812. 1998
  • Effects of c-MYC oncogene modulation on differentiation of human small cell lung carcinoma cell lines.  18:91-95. 1998
  • Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines..  18:91-95. 1998
  • Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer.  17:4639-4645. 1997
  • Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancer..  17:4639-4645. 1997
  • MDA468 growth inhibition by EGF is associated with the induction of the cyclin-dependent kinase inhibitor p21(WAF1).  17:2627-2633. 1997
  • Yttrium-90/indium-111-DOTA-peptide-chimeric L6: Pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer.  17:1735-1744. 1997
  • Yttrium-90/indium-111-DOTA-peptide-chimeric L6: pharmacokinetics, dosimetry and initial results in patients with incurable breast cancer..  17:1735-1744. 1997
  • Elevated expression of the neutrophil calcium-binding protein, MRP-14, in metastasis-enhancing neutrophils.  17:1-6. 1997
  • Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma.  16:2931-2936. 1996
  • Effect of microwave oven heating times on androgen receptor antigen retrieval from paraffin-embedded prostatic adenocarcinoma..  16:2931-2936. 1996
  • Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.  16:1963-1970. 1996
  • Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines..  16:1963-1970. 1996
  • Immunohistochemical evaluation of type IV collagenase (72-kd metalloproteinase) in prostatic intraepithelial neoplasia.  16:2057-2062. 1996
  • Transplantable melanomas in gerbils (Meriones unguiculatus). I. Origin, morphology and growth rate.  16:1203-1208. 1996
  • SOD2 (MnSOD) does not suppress tumorigenicity or metastasis of human melanoma C8161 cells.  15:2065-2070. 1995
  • Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones.  14:1743-1751. 1994
  • Frequency and location of mitoses in prostatic intraepithelial neoplasia (PIN).  13:2447-2451. 1993
  • Heterogenic properties of clonal cell lines derived from canine mammary carcinomas and sensitivity to tamoxifen and doxorubicin..  13:229-236. 1993
  • Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice.  13:593-597. 1993
  • Proliferating cell nuclear antigen (PCNA) in prostatic invasive adenocarcinoma. Is the proliferation state in the marginal zone of the tumour higher than in the central part?.  13:129-132. 1993
  • DOPA inhibits induced proliferative activity of murine and human lymphocytes.  12:753-756. 1992
  • Molecular mechanisms governing melanogenesis in hamster melanomas: Relative abundance of tyrosinase and catalase-B (gp 75).  11:257-262. 1991
  • Phenotypic changes of Ab hamster melanoma during long-term culture..  5:403-409. 1985
  • International Standard Serial Number (issn)

  • 0250-7005
  • Electronic International Standard Serial Number (eissn)

  • 1791-7530